Aida Pharmaceuticals Inc represents core values such as integrity, innovation, and excellence in the pharmaceutical industry. The company is committed to providing high-quality and cost-effective healthcare solutions to patients worldwide. With a strong emphasis on research and development, Aida Pharmaceuticals Inc strives to deliver innovative pharmaceutical products that meet the evolving needs of the market. Their corporate philosophy revolves around ensuring patient-centric care, maintaining ethical practices, and fostering a culture of transparency and accountability. Aida Pharmaceuticals Inc's dedication to improving global health makes them a reliable and trustworthy player in the pharmaceutical sector.

Aida Pharmaceuticals Inc is primarily present in several countries and regions around the world. The company has a strong presence in China, where it is headquartered. Additionally, Aida Pharmaceuticals Inc operates in various Asian countries, including Japan and South Korea, where it has established a significant market presence. Moreover, the company has expanded its reach to North America, particularly in the United States and Canada, by building strategic partnerships and establishing a distribution network. Aida Pharmaceuticals Inc's global presence showcases its commitment to serving diverse markets and exploring opportunities for growth and expansion.

Aida Pharmaceuticals Inc, a leading pharmaceutical company, has achieved significant milestones in its journey. Over the years, the company has made remarkable strides in the healthcare industry. Aida Pharmaceuticals Inc successfully expanded its product portfolio, introducing innovative and high-quality medications. The company also established strong partnerships with renowned healthcare organizations, enabling greater market reach and enhancing patient care. Furthermore, Aida Pharmaceuticals Inc has consistently demonstrated a commitment to research and development, leading to breakthrough advancements in medical science. These milestones have solidified Aida Pharmaceuticals Inc's position as a trusted and reputable player in the pharmaceutical sector, driving its continued growth and success.

Aida Pharmaceuticals Inc, a renowned company based in China, has a rich history and background. Established in 1999, it has developed into a leading pharmaceutical company with a diverse range of products and services. Aida Pharmaceuticals focuses on the research, development, manufacturing, and marketing of various healthcare and pharmaceutical products. With a strong emphasis on quality and innovation, the company has gained recognition both domestically and internationally. Aida Pharmaceuticals Inc's commitment to improving human health and addressing the evolving needs of the global healthcare market has positioned it as a trusted player in the pharmaceutical industry.

The main competitors of Aida Pharmaceuticals Inc in the market include both domestic and international pharmaceutical companies. Some notable competitors include ABC Pharmaceuticals, XYZ Pharmaceuticals, and Company Name Pharma. These competitors share a similar focus on the development and production of pharmaceutical products, competing for market share and customer base. Aida Pharmaceuticals Inc faces stiff competition in the industry, requiring continuous innovation, efficient marketing strategies, and high-quality product offerings to maintain a competitive edge in the market.

Aida Pharmaceuticals Inc is primarily active in the pharmaceutical industry.

The business model of Aida Pharmaceuticals Inc is focused on the development, manufacturing, and distribution of pharmaceutical products. Aida Pharmaceuticals Inc aims to provide high-quality medicines to meet the healthcare needs of patients worldwide. Through extensive research and collaboration with industry experts, Aida Pharmaceuticals Inc formulates innovative pharmaceutical solutions that address various medical conditions. The company adheres to strict quality standards in its manufacturing processes to ensure the safety and efficacy of its products. Aida Pharmaceuticals Inc also works towards establishing strategic partnerships and expanding its market presence to foster growth and deliver value to its shareholders.

KGV kan i øjeblikket ikke beregnes for Aida Pharmaceuticals.

KUV kan i øjeblikket ikke beregnes for Aida Pharmaceuticals.

AlleAktien Kvalitetsscore for Aida Pharmaceuticals er 4/10.

Omsætningen kan i øjeblikket ikke beregnes for Aida Pharmaceuticals.

Overskuddet kan i øjeblikket ikke beregnes for Aida Pharmaceuticals.

Aida Pharmaceuticals Inc. is a leading provider of pharmaceutical products, focusing on the manufacturing, development, and marketing of generic and specialized drugs. The company is headquartered in Hangzhou, China, and has been listed on the NASDAQ stock exchange since 2007. The business model includes manufacturing and marketing pharmaceutical products, research and development, as well as production and quality control processes. Aida Pharmaceuticals also engages in licensing and marketing pharmaceutical products worldwide. The company specializes in the production and marketing of generic drugs, offering a wide range of medications at significantly lower prices than brand-name drugs. They also manufacture and market specialized drugs under their own brand names, particularly in medical areas such as oncology and cardiology. In recent years, Aida Pharmaceuticals has expanded its focus to research and development, investing in the development of drugs for therapeutic areas such as oncology, neurology, and immunology. They have a strong emphasis on maintaining high-quality standards through efficient production and quality control processes. As an international company, Aida Pharmaceuticals has branches and sales teams in various regions around the world, including Asia, Europe, North America, Latin America, and Africa. In conclusion, Aida Pharmaceuticals Inc. is a leading provider of pharmaceutical products, with a focus on manufacturing, development, and marketing of generic and specialized drugs. They prioritize research and development, maintain an efficient production and quality control department, and market their products globally through licensing.

Aida Pharmaceuticals udbetaler et udbytte på 0 USD fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Aida Pharmaceuticals, eller selskabet udbetaler ikke udbytte.

ISIN'en for Aida Pharmaceuticals er US0087211027.

WKN for Aida Pharmaceuticals er A0YHEN.

Tickeren for Aida Pharmaceuticals er AIDA.

I løbet af de sidste 12 måneder betalte Aida Pharmaceuticals en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Aida Pharmaceuticals sandsynligvis betale en dividende på 0 USD.

Udbytteafkastet for Aida Pharmaceuticals er i øjeblikket .

Aida Pharmaceuticals betaler kvartalsvis udbytte. Dette uddeles i månederne .

Aida Pharmaceuticals betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 USD. Dette svarer til et dividendeafkast på 0 %.

Aida Pharmaceuticals bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Aida Pharmaceuticals fra den 21.9.2024 på 0 USD, skulle du have haft aktien i din portefølje før ex-datoen den 21.9.2024.

Udbetalingen af det sidste udbytte blev foretaget den 21.9.2024.

I løbet af 2023 udbetalte Aida Pharmaceuticals 0 USD i form af dividender.

Udbytterne fra Aida Pharmaceuticals udbetales i USD.